NINLARO 4mg (Ixazomib Capsule) 4mg

NINLARO 4mg (Ixazomib) capsules are prescribed for multiple myeloma treatment. This oral proteasome inhibitor supports therapy in adults when combined with other medications. Ideal for patients seeking targeted cancer care with convenient capsule form. Short-term storage at room temperature maintains efficacy.

Strength

4mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Takeda Pharma AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NINLARO 4mg capsules contain ixazomib, a proteasome inhibitor used in multiple myeloma therapy. It is typically prescribed alongside lenalidomide and dexamethasone for relapsed or refractory cases. This combination helps slow disease progression in adult patients. Commonly used as part of maintenance treatment after initial therapy.

Side Effects

NINLARO 4mg capsules work by blocking proteasome activity in cancer cells, which can slow tumor growth. Patients may experience gastrointestinal effects like nausea or diarrhea during treatment. Fatigue and low blood cell counts are also commonly reported. Regular monitoring helps manage these effects.

Precautions & Warnings

Store NINLARO 4mg capsules at room temperature away from moisture and heat. Keep out of reach of children and pets. Avoid opening or crushing capsules to prevent exposure. Report any signs of infection or unusual bleeding to a healthcare provider promptly. Pregnant or breastfeeding individuals should consult a doctor before use.

Avoid Interactions

NINLARO may interact with strong CYP3A inhibitors or inducers, affecting drug levels in the body. Grapefruit products should be avoided due to potential interaction risks. Certain vaccines and herbal supplements may also interfere with its effects. Always inform your healthcare provider about all medications being taken.

Frequently Asked Questions

NINLARO 4mg (ixazomib) is used to treat multiple myeloma in adults, often in combination with other medications.

Store at room temperature, away from moisture and heat. Keep the container tightly closed when not in use.

Common effects include nausea, diarrhea, fatigue, and low blood cell counts. Regular monitoring is recommended.

Consult a healthcare provider before combining with other drugs, as interactions may occur with CYP3A inhibitors or inducers.

Pregnant individuals should discuss risks with a doctor, as the effects on fetal development are not fully known.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.